Bicara Non Current Assets Total vs Capital Stock Analysis
| BCAX Stock | 20.79 0.17 0.81% |
Bicara Therapeutics financial indicator trend analysis is way more than just evaluating Bicara Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bicara Therapeutics is a good investment. Please check the relationship between Bicara Therapeutics Non Current Assets Total and its Capital Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicara Therapeutics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Non Current Assets Total vs Capital Stock
Non Current Assets Total vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bicara Therapeutics Non Current Assets Total account and Capital Stock. At this time, the significance of the direction appears to have pay attention.
The correlation between Bicara Therapeutics' Non Current Assets Total and Capital Stock is -0.86. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Bicara Therapeutics Common, assuming nothing else is changed. The correlation between historical values of Bicara Therapeutics' Non Current Assets Total and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Bicara Therapeutics Common are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Non Current Assets Total i.e., Bicara Therapeutics' Non Current Assets Total and Capital Stock go up and down completely randomly.
Correlation Coefficient | -0.86 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.Most indicators from Bicara Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bicara Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicara Therapeutics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Tax Provision is likely to drop to 3,300 in 2024. Selling General Administrative is likely to drop to about 8.6 M in 2024
| 2010 | 2023 | 2024 (projected) | Total Operating Expenses | 37.7M | 39.9M | 42.6M | Research Development | 31.3M | 30.6M | 24.8M |
Bicara Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Bicara Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bicara Stock Analysis
When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.